546 related articles for article (PubMed ID: 33418929)
1. IL-12 Family Cytokines in Cancer and Immunotherapy.
Mirlekar B; Pylayeva-Gupta Y
Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33418929
[TBL] [Abstract][Full Text] [Related]
2. Immunomodulatory Effects of IL-2 and IL-15; Implications for Cancer Immunotherapy.
Yang Y; Lundqvist A
Cancers (Basel); 2020 Nov; 12(12):. PubMed ID: 33266177
[TBL] [Abstract][Full Text] [Related]
3. Anti-cancer Therapies Employing IL-2 Cytokine Tumor Targeting: Contribution of Innate, Adaptive and Immunosuppressive Cells in the Anti-tumor Efficacy.
Mortara L; Balza E; Bruno A; Poggi A; Orecchia P; Carnemolla B
Front Immunol; 2018; 9():2905. PubMed ID: 30619269
[TBL] [Abstract][Full Text] [Related]
4. IL-27, IL-30, and IL-35: A Cytokine Triumvirate in Cancer.
Kourko O; Seaver K; Odoardi N; Basta S; Gee K
Front Oncol; 2019; 9():969. PubMed ID: 31681561
[TBL] [Abstract][Full Text] [Related]
5. Crosstalk of Inflammatory Cytokines within the Breast Tumor Microenvironment.
Habanjar O; Bingula R; Decombat C; Diab-Assaf M; Caldefie-Chezet F; Delort L
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835413
[TBL] [Abstract][Full Text] [Related]
6. Molecular immunological approaches to biotherapy of human cancers--a review, hypothesis and implications.
Becker Y
Anticancer Res; 2006; 26(2A):1113-34. PubMed ID: 16619514
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy of cancer by IL-12-based cytokine combinations.
Weiss JM; Subleski JJ; Wigginton JM; Wiltrout RH
Expert Opin Biol Ther; 2007 Nov; 7(11):1705-21. PubMed ID: 17961093
[TBL] [Abstract][Full Text] [Related]
8. The Pro-tumorigenic IL-33 Involved in Antitumor Immunity: A Yin and Yang Cytokine.
Fournié JJ; Poupot M
Front Immunol; 2018; 9():2506. PubMed ID: 30416507
[TBL] [Abstract][Full Text] [Related]
9. Expanding Diversity in Molecular Structures and Functions of the IL-6/IL-12 Heterodimeric Cytokine Family.
Hasegawa H; Mizoguchi I; Chiba Y; Ohashi M; Xu M; Yoshimoto T
Front Immunol; 2016; 7():479. PubMed ID: 27867385
[TBL] [Abstract][Full Text] [Related]
10. Autonomous IL-36R signaling in neutrophils activates potent antitumor effector functions.
Roy S; Fitzgerald K; Lalani A; Lai CW; Kim A; Kim J; Ou P; Mirsoian A; Liu X; Ramrakhiani A; Zhao H; Zhou H; Xu H; Meisen H; Li CM; Lugt BV; Thibault S; Tinberg CE; DeVoss J; Egen J; Wu LC; Noubade R
J Clin Invest; 2023 Jun; 133(12):. PubMed ID: 37317970
[TBL] [Abstract][Full Text] [Related]
11. Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-γ, CXCL9 and CXCL10.
Bergamaschi C; Pandit H; Nagy BA; Stellas D; Jensen SM; Bear J; Cam M; Valentin A; Fox BA; Felber BK; Pavlakis GN
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32461349
[TBL] [Abstract][Full Text] [Related]
12. Regulation of NK Cell Activation and Effector Functions by the IL-12 Family of Cytokines: The Case of IL-27.
Zwirner NW; Ziblat A
Front Immunol; 2017; 8():25. PubMed ID: 28154569
[TBL] [Abstract][Full Text] [Related]
13. Combination of cancer vaccine with CD122-biased IL-2/anti-IL-2 Ab complex shapes the stem-like effector NK and CD8
Shimizu K; Ueda S; Kawamura M; Aoshima H; Satoh M; Nakabayashi J; Fujii SI
J Immunother Cancer; 2023 Jul; 11(7):. PubMed ID: 37400134
[TBL] [Abstract][Full Text] [Related]
14. IL-27, a pleiotropic cytokine for fine-tuning the immune response in cancer.
Beizavi Z; Zohouri M; Asadipour M; Ghaderi A
Int Rev Immunol; 2021; 40(5):319-329. PubMed ID: 33146571
[TBL] [Abstract][Full Text] [Related]
15. Orchestration of immune response by innate lymphoid cell subtype 2 at various tumor microenvironment, a suitable target for cancer immunotherapy.
Roy R; Das T; Biswas N
Int Rev Immunol; 2024; 43(2):74-82. PubMed ID: 37599626
[TBL] [Abstract][Full Text] [Related]
16. The Janus Face of IL-33 Signaling in Tumor Development and Immune Escape.
Choi MR; Sosman JA; Zhang B
Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34209038
[TBL] [Abstract][Full Text] [Related]
17. Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).
Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R
Clin Ter; 2006; 157(4):377-86. PubMed ID: 17051976
[TBL] [Abstract][Full Text] [Related]
18. The Role of Natural Killer Cells in Autoimmune Diseases.
Kucuksezer UC; Aktas Cetin E; Esen F; Tahrali I; Akdeniz N; Gelmez MY; Deniz G
Front Immunol; 2021; 12():622306. PubMed ID: 33717125
[TBL] [Abstract][Full Text] [Related]
19. Positive & Negative Roles of Innate Effector Cells in Controlling Cancer Progression.
Stolk D; van der Vliet HJ; de Gruijl TD; van Kooyk Y; Exley MA
Front Immunol; 2018; 9():1990. PubMed ID: 30298063
[TBL] [Abstract][Full Text] [Related]
20. Role of innate lymphocytes in infection and inflammation.
Koyasu S; Moro K
Front Immunol; 2012; 3():101. PubMed ID: 22783250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
